Related Experiment Videos
[Current therapy of meningococcal infection in childhood]
Helvetica Paediatrica Acta
|April 1, 1985
Insights
This article details managing acute meningococcal septicemia. Early, aggressive shock and respiratory support, alongside antibiotics, are crucial. Corticosteroids may play a role, but anticoagulants and related therapies are not recommended.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pediatrics
Context:
- Acute meningococcal septicemia presents a severe, life-threatening condition.
- Effective management requires a multidisciplinary approach.
- Current therapeutic strategies are continuously evolving.
Purpose:
- To outline current best practices for managing acute meningococcal septicemia.
- To emphasize the critical role of supportive care alongside antimicrobial therapy.
- To provide guidance on the judicious use of adjunctive therapies.
Summary:
- Antibiotic therapy remains the cornerstone of treatment for meningococcal septicemia.
- Early and aggressive management of shock and respiratory failure, including endotracheal intubation and mechanical ventilation, is paramount.
- The use of corticosteroids is considered, while anticoagulants, fibrinolytic agents, and inhibitors of fibrinolysis are generally discouraged.
Impact:
- Improved patient outcomes and reduced mortality in acute meningococcal septicemia.
- Standardization of care protocols for this severe infection.
- Informed clinical decision-making regarding supportive and adjunctive treatments.
Abstract:
The article discusses the present therapy of acute meningococcal septicemia. Besides adequate antibiotic treatment, the importance of early and aggressive shock and respiratory therapy, i.e. endotracheal intubation and mechanical ventilation, is stressed. The role of corticosteroids is discussed. The use of anticoagulants, fibrinolytic agents and inhibitors of fibrinolysis is discouraged.